Aurobindo Pharma Limited AUROPHARMA

Latest filings

• Routine15 24 Sept, 10:51 · NSE
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
• Routine15 21 Sept, 16:05 · BSE
  Intimation of investor Analyst meet scheduled on 24.09.2026.
• Routine15 21 Sept, 16:03 · NSE
  Schedule of meet
• General25 15 Sept, 18:11 · NSE
  Completion of US FDA Inspection at Unit-II of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company.
• Approval73 15 Sept, 13:03 · NSE
  A press release dated September 15, 2026, titled "Aurobindo Pharma receives USFDA Final Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol, 40 mcg and 80 mcg".
• M&A73 12 Sept, 12:41 · NSE
  Acquisition
• General25 11 Sept, 17:31 · NSE
  Completion of US FDA Inspection at Unit-IV of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company
• Routine15 11 Sept, 16:43 · NSE
  Schedule of meet
• Routine15 11 Sept, 16:41 · NSE
  Schedule of meet
• Routine15 11 Sept, 16:39 · NSE
  Schedule of meet

Shown 15 minutes after publication. Real time with Pro.

Upcoming corporate actions

No announced actions in the next 60 days.